QBFM
CRL icon

QS Batterymarch Financial Management’s Charles River Laboratories CRL Stock Holding History

QS Batterymarch Financial Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10.8M Hold
180,340
– – 0.28% 96
2014
Q2 		$9.65M Sell
180,340
-51,500
-22% -$2.83M 0.24% 114
2014
Q1 		$14M Buy
231,840
+7,300
+3% +$426K 0.29% 93
2013
Q4 		$11.9M Sell
224,540
-9,300
-4% -$467K 0.25% 113
2013
Q3 		$10.8M Buy
233,840
+8,230
+4% +$378K 0.24% 128
2013
Q2 		$9.26M Buy
+225,610
New +$9.67M 0.18% 156

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QS Batterymarch Financial Management's CRL Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Charles River Laboratories (CRL) position steady in Q3 2014 at 180,340 shares worth $10.8M. The position accounts for 0.28% of the portfolio, ranked #96.

QS Batterymarch Financial Management first reported a position in CRL in Q2 2013 and has held it in 6 quarters since. The position peaked at $14M in Q1 2014. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • QS Batterymarch Financial Management held 180,340 shares of Charles River Laboratories worth $10.8M as of Q3 2014.
  • QS Batterymarch Financial Management left its Charles River Laboratories share count unchanged in Q3 2014.
  • Charles River Laboratories made up 0.28% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #96 holding.
  • QS Batterymarch Financial Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Charles River Laboratories position peaked at $14M in Q1 2014.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.